Skip to content
OpenCapital
Get started

Edgewise Therapeutics, Inc. EWTX Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Cytokinetics logo
CytokineticsCYTK
$8.12B+70.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$5.64B+40.3%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$3.02B+2.7%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$2.99B+153%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$3.76B+38.7%

Other financials

Income statement

See full
Operating income-$54.1M-17.7%
Net income-$49.0M-20.1%
EPS (diluted)-$0.46-7.0%

Balance sheet

See full
Cash & equivalents$33.2M-33.5%
Total debt$3.8M-16.8%
Total equity$493.2M+14.8%
Total assets$518.5M+14.1%

Cash flow

See full
Operating cash flow-$42.5M-12.4%
CapEx$260.0K+491%
Free cash flow-$42.8M-12.9%

Valuation

See full
Enterprise value$3.93B+63.5%

Returns & leverage

See full
Return on equity-38.1%+13.4pp
Debt / equity0×0.0×
Current ratio22.6×+1.6×

Where this comes from

Computed from the period-end share price: $3.38B.

The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edgewise Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edgewise Therapeutics, Inc.'s market capitalization?
Edgewise Therapeutics, Inc. (EWTX) reported market capitalization of $3.38B in Q1 2026.
How has Edgewise Therapeutics, Inc.'s market capitalization changed year-over-year?
Edgewise Therapeutics, Inc.'s market capitalization increased by 61.3% year-over-year, from $2.09B to $3.38B.
What is the long-term trend for Edgewise Therapeutics, Inc.'s market capitalization?
Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s market capitalization has grown at a 36.5% compound annual growth rate (CAGR), from $757.04M to $2.63B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.